Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anal Dilatation Plus Probiotics for LARS
NCT04688242Phase 2Unknown
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Feb 2021
- Primary completion
- Dec 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Bio-three in low anterior resection syndrome (LARS), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Status: unknown.
02
Drugs
Bio-three
03
Conditions
low anterior resection syndrome (LARS)
Beyond the preview
Go deeper on NCT04688242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04688242.